Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer

D Lavacchi, S Fancelli, G Roviello, F Castiglione… - Frontiers in …, 2022 - frontiersin.org
p=0.012), while a trend in favor of the lack of surgery on primary tumor was observed in
G13D mutation (1-sided p=… hotspots mutation of KRAS with the remaining overall KRAS-mutated

Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients

Y Yuan, Y Liu, Y Wu, J Zhang, C Shen… - The International …, 2021 - journals.sagepub.com
… Although the predictive effect of KRAS mutations on EGFR … OS and PFS, but not other tumors
with KRAS mutations. A meta-… therapy in KRAS G13D and other KRAS-mutated metastatic …

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients

A Koulouridi, M Karagianni, I Messaritakis… - Cancers, 2022 - mdpi.com
… the proven predictive significance of KRAS mutations in CRC … % of RAS-mutated patients
were KRAS mutants, with G12D … mutations were G12D (33.1%), G12V (21.2%) and G13D (16.7…

Study of Ras mutations' prognostic value in metastatic colorectal cancer: STORIA analysis

…, AM Rachiglio, C Roma, MR Maiello, S Scala, P Delrio… - Cancers, 2020 - mdpi.com
mutant KRAS is a negative prognostic factor and that p.G12C/… G12C variant predicted shorter
survival (HR: 2.26, p = 0.001) … G13D KRAS mutation had better survival. In this light, it was …

KRAS mutations predict response and outcome in advanced lung adenocarcinoma patients receiving first-line bevacizumab and platinum-based chemotherapy

ÁK Ghimessy, Á Gellert, E Schlegl, B Hegedus, E Raso… - Cancers, 2019 - mdpi.com
… subtypes (G12A, G12R, G12S, G13C and G13D) were also found in the BEV group. … the
clinical relevance of KRAS mutations, we performed comparative statistical analyses of KRAS

[HTML][HTML] Impact of kras mutations in clinical features in colorectal cancer

RM Zanatto, G Santos, JC Oliveira… - … Brasileiros de Cirurgia …, 2020 - SciELO Brasil
G13D). Não foi encontrada correlação entre a mutação KRAS ea idade (p=0,646) ou o
gênero (p… The KRAS mutation is a predictor of a negative response to treatment with EGFR …

[HTML][HTML] Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases

…, E Milone, A Donini, P Fugazzola, P Faviana… - ESMO open, 2024 - Elsevier
… This study aims to determine the prevalence of specific KRAS mutations and their … mutations
occurred in the P-loop region (codons 12 and 13, 91.3% of cases); G12D, G12V and G13D

Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer

…, FA Helfritz, M Stuschke, B Schumacher, P Markus… - Oncogene, 2019 - nature.com
… yielded a good prediction of those KRAS codon 12 mutations truly … mutation was much less
prevalent than predicted from … In our prospectively acquired cohorts, KRAS G13D exhibited a …

[HTML][HTML] A real-world study in advanced non–small cell lung cancer with KRAS mutations

L Lei, W Wang, Z Yu, X Liang, W Pan, H Chen… - Translational …, 2020 - Elsevier
… , P < 0.05), but not second-line chemotherapies. CONCLUSION: The KRAS G12C mutation
could be a predictive … Other identified KRAS mutations included G12S, G12R, G13C, G13D, …

Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention

C Johnson, DL Burkhart, KM Haigis - Cancer discovery, 2022 - AACR
… on the surface or in the core of KRAS that are predicted to … of therapeutic strategies across
mutants of the same class. For … cancers harboring G13D, but not Gly12, mutants of KRAS (99). …